Allegion (NYSE:ALLE) PT Raised to $132.00 at UBS Group

Allegion (NYSE:ALLE) had its target price upped by UBS Group from $113.00 to $132.00 in a research note issued to investors on Tuesday, Benzinga reports. UBS Group currently has a neutral rating on the scientific and technical instruments company’s stock.

Several other brokerages have also recently commented on ALLE. Barclays raised their target price on shares of Allegion from $121.00 to $122.00 and gave the stock an equal weight rating in a report on Tuesday, April 2nd. Mizuho cut shares of Allegion from a buy rating to a neutral rating and raised their target price for the stock from $140.00 to $141.00 in a report on Friday, February 23rd. Wells Fargo & Company cut shares of Allegion from an overweight rating to an equal weight rating and raised their target price for the stock from $139.00 to $140.00 in a report on Wednesday, February 21st. Finally, StockNews.com upgraded shares of Allegion from a hold rating to a buy rating in a report on Wednesday, April 10th. Six equities research analysts have rated the stock with a hold rating and one has given a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of Hold and an average target price of $127.83.

Allegion Stock Down 0.4 %

Allegion stock opened at $126.39 on Tuesday. The stock has a market cap of $11.07 billion, a price-to-earnings ratio of 20.65, a PEG ratio of 4.59 and a beta of 1.14. The company has a current ratio of 1.26, a quick ratio of 0.85 and a debt-to-equity ratio of 1.22. The company’s 50-day moving average price is $131.05 and its two-hundred day moving average price is $118.49. Allegion has a 52 week low of $95.94 and a 52 week high of $136.91.

Allegion (NYSE:ALLE) last posted its quarterly earnings data on Tuesday, February 20th. The scientific and technical instruments company reported $1.68 earnings per share for the quarter, beating the consensus estimate of $1.59 by $0.09. Allegion had a net margin of 14.80% and a return on equity of 51.95%. The company had revenue of $897.40 million during the quarter, compared to analyst estimates of $904.17 million. During the same quarter last year, the firm posted $1.60 EPS. The business’s revenue for the quarter was up 4.2% on a year-over-year basis. On average, analysts expect that Allegion will post 7.01 EPS for the current fiscal year.

Allegion Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a dividend yield of 1.52%. The ex-dividend date is Thursday, June 13th. Allegion’s dividend payout ratio is currently 31.37%.

Insider Activity at Allegion

In other Allegion news, CEO John H. Stone bought 10,000 shares of Allegion stock in a transaction on Thursday, February 22nd. The stock was purchased at an average cost of $132.41 per share, for a total transaction of $1,324,100.00. Following the completion of the purchase, the chief executive officer now directly owns 104,248 shares of the company’s stock, valued at $13,803,477.68. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Allegion news, CEO John H. Stone bought 10,000 shares of Allegion stock in a transaction on Thursday, February 22nd. The stock was purchased at an average cost of $132.41 per share, for a total transaction of $1,324,100.00. Following the completion of the purchase, the chief executive officer now directly owns 104,248 shares of the company’s stock, valued at $13,803,477.68. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, SVP Robert C. Martens sold 5,391 shares of the business’s stock in a transaction on Thursday, February 22nd. The stock was sold at an average price of $132.84, for a total transaction of $716,140.44. Following the completion of the sale, the senior vice president now owns 7,555 shares of the company’s stock, valued at $1,003,606.20. The disclosure for this sale can be found here. Insiders own 0.90% of the company’s stock.

Institutional Trading of Allegion

A number of institutional investors and hedge funds have recently modified their holdings of the company. Compass Wealth Management LLC acquired a new position in Allegion during the 4th quarter valued at $25,000. CVA Family Office LLC acquired a new position in Allegion during the 4th quarter valued at $28,000. Robeco Institutional Asset Management B.V. raised its stake in Allegion by 19.3% during the 4th quarter. Robeco Institutional Asset Management B.V. now owns 23,634 shares of the scientific and technical instruments company’s stock valued at $30,000 after purchasing an additional 3,823 shares during the last quarter. Benjamin Edwards Inc. raised its stake in Allegion by 123.1% during the 2nd quarter. Benjamin Edwards Inc. now owns 261 shares of the scientific and technical instruments company’s stock valued at $31,000 after purchasing an additional 144 shares during the last quarter. Finally, Ancora Advisors LLC raised its stake in Allegion by 153.3% during the 3rd quarter. Ancora Advisors LLC now owns 380 shares of the scientific and technical instruments company’s stock valued at $40,000 after purchasing an additional 230 shares during the last quarter. 92.21% of the stock is currently owned by institutional investors and hedge funds.

About Allegion

Allegion plc manufactures and sells mechanical and electronic security products and solutions worldwide. The company offers door controls and systems and exit devices; locks, locksets, portable locks, and key systems and services; electronic security products and access control systems; time, attendance, and workforce productivity systems; doors, accessories, and other.